Medical Cannabis Market Size, Share, Growth, Industry Overview, Growth Factors, SWOT Analysis and Forecast 2023-2028
IMARC Group, a leading market research company, has recently releases report titled “Medical Cannabis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, The study provides a detailed analysis of the industry, including the global medical cannabis market size, share, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
Report Highlights:
How big is the medical cannabis market?
| Report Attributes | Details |
| Market Size in 2022 | US$ 31.8 Billion |
| Market Forecast in 2028 | US$ 57.4 Billion |
| Growth rate (2023 to 2028) | CAGR of 8.47% |
| Base Year of the Analysis | 2022 |
| Forecast Period | 2023-2028 |
What is Medical Cannabis?
Cannabis, also referred to as marijuana, represents a psychoactive drug that is emanated from the cannabis plant of the Cannabaceae family. It was utilized medicinally in ancient Chinese, Egyptian, Indian, and Islamic cultures. It is extensively used for treating various diseases and symptoms, such as chronic pain, depression, arthritis, diabetes, cancer, migraines, epilepsy, multiple sclerosis, acquired immunodeficiency syndrome (AIDS), glaucoma, post-traumatic stress disorder (PTSD), amyotrophic lateral sclerosis (ALS), Alzheimer’s, Parkinson’s, and Tourette’s. Owing to its therapeutic benefits, cannabis has been approved for medical use in several countries, including Canada, Chile, Colombia, the Czech Republic, Argentina, Brazil, Germany, Italy, Mexico, Spain, the United States, Uruguay, and the United Kingdom with varying degrees of legal restrictions.
Request for a free sample copy of this report: https://www.imarcgroup.com/medical-cannabis-market/requestsample
What are the growth prospects and trends in the medical cannabis industry?
The escalating product demand to enhance efficacy or to combat adverse side effects of therapies, as it is safer and has less intense outcomes compared to other treatment options, is among the primary factors driving the medical cannabis market. Besides this, this drug is very effective in reducing nausea and boosting appetite in chemotherapy patients and is also used in combination with traditional opioid painkillers that enables patients to lower the dosage and frequency of opioids considerably and impart enhanced pain relief, which is further augmenting the market growth. Moreover, the elevating requirement for medical cannabis for various medical purposes, such as muscle relaxers, to ease labor pains in women, and as a condiment in cooking is also catalyzing the global market. Apart from this, the growing geriatric population that is more likely to develop chronic illnesses, the increasing clinical trials, and the commercialization of marijuana-based indications are expected to bolster the medical cannabis market in the coming years.
Who are the key players operating in the industry?
The report covers the major market players including:
- Canopy Growth Corporation
- GW Pharmaceuticals, plc
- Aurora Cannabis, Inc.
- Aphria, Inc.
- MedReleaf Corporation
- Insys Therapeutics, Inc.
- CanniMed Therapeutics, Inc.
- Cara Therapeutics, Inc.
- United Cannabis Corporation
What is included in market segmentation?
The report has segmented the market into the following categories:
Breakup by Species:
- Indica
- Sativa
- Hybrid
Breakup by Derivatives:
- Cannabidiol (CBD)
- Tetrahydrocannabinol (THC)
- Others
Breakup by Application:
- Cancer
- Arthritis
- Migraine
- Epilepsy
- Others
Breakup by End-Use:
- Pharmaceutical Industry
- Research and Development Centres
- Others
Breakup by Route of Administration:
- Oral Solutions and Capsules
- Vaporizers
- Topicals
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Turkey, South Africa, Others)
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=1053&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group/mycompany/
